Evolution and mechanism of restriction of herpesviruses by MxB

MxB限制疱疹病毒的进化和机制

基本信息

  • 批准号:
    10667144
  • 负责人:
  • 金额:
    $ 26.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-21 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Herpesviruses cause a substantial worldwide burden on human health. In response to infections by these and other pathogens, host cells express thousands of interferon-stimulated genes. One such gene encodes the myxovirus resistance protein B (MxB) that potently restricts several herpesviruses, including herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), and cytomegalovirus (CMV). MxB has been undergoing rapid evolution in primates, as reflected in genetic signatures of positive selection, suggesting that MxB has been engaged in arms races with viruses over millions of years. Intriguingly, unlike human MxB, the MxB alleles from several non-human primates do not inhibit HSV-1 replication. In contrast, all tested orthologs retain antiviral activity against CMV. These results suggest that human MxB, but not non-human primate orthologs, including the closely related chimpanzee gene, has evolved to restrict HSV-1. This scenario appears to be a rare example of the host side “winning” during an evolutionary arms race with a virus. To dissect the mechanism MxB utilizes to restrict HSV-1, studies in Aim 1 will define the role of specific residues that are necessary and sufficient to explain differing restrictive phenotypes of human and chimpanzee MxB orthologs. Experiments aiming to identify viral factors that are the targets of MxB, as well as which host co-factors are potentially required, will employ proximity ligation assays coupled with mass spectrometry. Building on the observation that HSV-2 strains vary in their sensitivity to human and chimpanzee MxB, Aim 2 will identify which other primate MxB orthologs restrict which strains of HSV-2, which will help elucidate the evolutionary trajectory of the development of the phenotype. Additionally, because human MxB restricts only a subset of HSV-2 strains, analyses of sequence differences among the strains will aid in the identification of viral determinants of MxB sensitivity. Together, this proposal will reveal the critical factors mediating the arms races between MxB and herpes simplex viruses and will aid in elucidating the anti-herpesvirus mechanism of MxB.
项目总结/摘要 疱疹病毒在世界范围内对人类健康造成巨大负担。为了应对这些感染, 在其它病原体中,宿主细胞表达数千个干扰素刺激的基因。一个这样的基因编码 一种粘液病毒抗性蛋白B(Mx B),有效限制包括单纯疱疹病毒在内的几种疱疹病毒 病毒1(HSV-1)、单纯疱疹病毒2(HSV-2)和巨细胞病毒(CMV)。MxB一直在经历快速的 灵长类动物的进化,正如正选择的遗传特征所反映的那样,这表明MxB一直是 数百万年来一直在与病毒进行军备竞赛。有趣的是,与人类MxB不同,来自人类的MxB等位基因 几种非人灵长类动物不抑制HSV-1复制。相比之下,所有测试的直系同源物都保留了抗病毒活性。 抗CMV活性。这些结果表明,人MxB,而非非人灵长类直系同源物,包括 与黑猩猩基因密切相关的基因,已经进化为限制HSV-1。这种情况似乎是一个罕见的例子, 宿主方在与病毒的进化军备竞赛中“获胜”。为了剖析MxB利用的机制 为了限制HSV-1,目标1中的研究将确定特定残基的作用,这些残基是必要的,足以 解释人类和黑猩猩MxB同源基因的不同限制性表型。旨在识别 作为MxB靶点的病毒因子,以及可能需要的宿主辅因子, 邻位连接测定结合质谱法。根据观察,HSV-2病毒株 在它们对人类和黑猩猩MxB敏感性方面,Aim 2将鉴定哪些其他灵长类MxB直系同源物限制 这将有助于阐明表型发展的进化轨迹。 此外,由于人MxB仅限制HSV-2毒株的一个子集,因此序列差异的分析 将有助于鉴定MxB敏感性的病毒决定簇。总之,这一提议将 揭示了介导MxB和单纯疱疹病毒之间军备竞赛的关键因素,并将有助于 阐明MxB抗疱疹病毒的作用机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADAM P. GEBALLE其他文献

ADAM P. GEBALLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADAM P. GEBALLE', 18)}}的其他基金

Roles and regulation of polyamines during HCMV infection
多胺在 HCMV 感染过程中的作用和调节
  • 批准号:
    10308688
  • 财政年份:
    2020
  • 资助金额:
    $ 26.4万
  • 项目类别:
Evolution and mechanisms of cytomegalovirus antagonism of host cell defenses
巨细胞病毒拮抗宿主细胞防御的进化和机制
  • 批准号:
    10630815
  • 财政年份:
    2020
  • 资助金额:
    $ 26.4万
  • 项目类别:
Roles and regulation of polyamines during HCMV infection
多胺在 HCMV 感染过程中的作用和调节
  • 批准号:
    10593450
  • 财政年份:
    2020
  • 资助金额:
    $ 26.4万
  • 项目类别:
Evolution and mechanisms of cytomegalovirus antagonism of host cell defenses
巨细胞病毒拮抗宿主细胞防御的进化和机制
  • 批准号:
    10376227
  • 财政年份:
    2020
  • 资助金额:
    $ 26.4万
  • 项目类别:
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
优化免疫和母体宿主防御先天性巨细胞病毒感染的能力
  • 批准号:
    10434692
  • 财政年份:
    2019
  • 资助金额:
    $ 26.4万
  • 项目类别:
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
优化免疫和母体宿主防御先天性巨细胞病毒感染的能力
  • 批准号:
    10005407
  • 财政年份:
    2019
  • 资助金额:
    $ 26.4万
  • 项目类别:
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
优化免疫和母体宿主防御先天性巨细胞病毒感染的能力
  • 批准号:
    10188583
  • 财政年份:
    2019
  • 资助金额:
    $ 26.4万
  • 项目类别:
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
优化免疫和母体宿主防御先天性巨细胞病毒感染的能力
  • 批准号:
    10626882
  • 财政年份:
    2019
  • 资助金额:
    $ 26.4万
  • 项目类别:
Roles of Experimentally Evolved Vaccinia Mutations in Antagonizing Cell Defenses
实验进化的痘苗突变在拮抗细胞防御中的作用
  • 批准号:
    8848032
  • 财政年份:
    2014
  • 资助金额:
    $ 26.4万
  • 项目类别:
Roles of Experimentally Evolved Vaccinia Mutations in Antagonizing Cell Defenses
实验进化的痘苗突变在拮抗细胞防御中的作用
  • 批准号:
    8769973
  • 财政年份:
    2014
  • 资助金额:
    $ 26.4万
  • 项目类别:

相似海外基金

Tracing the African roots of Sri-Lanka Portuguese
追溯斯里兰卡葡萄牙语的非洲根源
  • 批准号:
    AH/Z505717/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Commercialisation of African Youth Enterprise Programme
非洲青年企业计划商业化
  • 批准号:
    ES/Y010752/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Resilient and Equitable Nature-based Pathways in Southern African Rangelands (REPAiR)
南部非洲牧场弹性且公平的基于自然的途径 (REPAiR)
  • 批准号:
    NE/Z503459/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Evaluating the effectiveness and sustainability of integrating helminth control with seasonal malaria chemoprevention in West African children
评估西非儿童蠕虫控制与季节性疟疾化学预防相结合的有效性和可持续性
  • 批准号:
    MR/X023133/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Fellowship
Understanding differences in host responses to African swine fever virus
了解宿主对非洲猪瘟病毒反应的差异
  • 批准号:
    BB/Z514457/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Fellowship
The impact on human health of restoring degraded African drylands
恢复退化的非洲旱地对人类健康的影响
  • 批准号:
    MR/Y019806/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
CAREER: Habitability of the Hadean Earth - A South African perspective
职业:冥古宙地球的宜居性——南非的视角
  • 批准号:
    2336044
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Continuing Grant
Nowcasting with Artificial Intelligence for African Rainfall: NAIAR
利用人工智能预测非洲降雨量:NAIAR
  • 批准号:
    NE/Y000420/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Research Grant
Assessing the role of the lithospheric mantle during passive margin development - insights from the South Atlantic African margin
评估岩石圈地幔在被动边缘发育过程中的作用 - 来自南大西洋非洲边缘的见解
  • 批准号:
    2305552
  • 财政年份:
    2024
  • 资助金额:
    $ 26.4万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了